Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-21-014932
Filing Date
2021-08-10
Accepted
2021-08-10 16:56:20
Documents
2
Period of Report
2021-08-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1744
2 mallikpoa.htm EX-24 4928
  Complete submission text file 0001567619-21-014932.txt   8074
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Issuer) CIK: 0001604464 (see all company filings)

EIN.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O RAFAEL HOLDINGS, INC. 520 BROAD ST NEWARK NJ 07102
Business Address
MALLIK AMEET (Reporting) CIK: 0001861441 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36548 | Film No.: 211160696